IMMUNOTHERAPY OR TARGETED THERAPY FOR ONCOGENE ADDICTED MELANOMA
Choice of immunotherapy vs targeted therapy in first line (BRAF)
J. Larkin
Choice of immunotherapy vs targeted therapy in first line (BRAF)
J. Larkin